Casaul, Karen L.

Antimycotic activity of chitosan derived from Litopenaeus vannamei (whiteleg shrimp) shells against candida auris / Karen L. Casaul, [and seven others]. - viii, 103 pages : colored illustration ; 28 cm.

Includes bibliographic references.

ABSTRACT - - Candida auris is a rising threat in healthcare due to its ability to resist many antifungal
drugs and cause serious infections. Because of this, there is an urgent need for alternative
treatments. This study aimed to evaluate the antimycotic activity of chitosan extracted from
Litopenaeus vannamei (Whiteleg Shrimp) shells against clinical isolates of Candida auris.
Chitosan was obtained through demineralization, deproteinization, and deacetylation
processes, then confirmed through X-ray diffraction and Fourier-transform infrared
spectroscopy. Moreover, to assess antifungal activity, two isolates of C. auris were exposed to
different concentrations of chitosan using the broth microdilution method and Kirby-Bauer
disk diffusion test. As a result, a distinct dose dependent effect was seen in the data, with
greater chitosan concentrations (up to 1000 μg/mL) inhibiting fungal growth more successfully
than lower concentrations, particularly in wound isolates. Furthermore, the clinical isolate from
the ear canal was resistant to Amphotericin B, although it was still susceptible to the majority
of chitosan concentrations, Caspofungin, and Fluconazole. Every treatment was effective on
the wound alone. Additionally, these results imply that chitosan, a naturally occurring
substance made from seafood waste, may be a viable and sustainable substitute for
manufactured antifungal medications, particularly when treating resistant strains such as C.
Auris. Opportunities for the advancement of shell-based antifungal drugs in pharmaceutical
and medical applications are also presented by this work.

T MTech A58c 2025